Fred Petrunak, OD
Optometrist · Altoona, PANPI 1700844024
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations.
Across 73 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$272
- Alcon$175
- Coopervision Inc.$174
- Johnson & Johnson Vision Care, Inc.$161
- Novartis$143
- Sun Pharmaceutical Industries Inc.$119
- plus $514 from 12 others
What the payments were for
- Food & beverage$1,54199%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 10 | $272 |
| Alcon | 10 | $175 |
| Coopervision Inc. | 5 | $174 |
| Johnson & Johnson Vision Care, Inc. | 7 | $161 |
| Novartis | 9 | $143 |
| Sun Pharmaceutical Industries Inc. | 7 | $119 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $109 |
| Topcon Healthcare, Inc. | 1 | $83 |
| Kala Pharmaceuticals, Inc. | 3 | $48 |
| Dompe US, Inc. | 2 | $48 |
| Sight Sciences, Inc. | 2 | $41 |
| Oyster Point Pharma, Inc. | 3 | $39 |
| Thea Pharma Inc. | 2 | $33 |
| LKC Technologies, Inc. | 1 | $32 |
| Sanofi | 1 | $23 |
| Tarsus Pharmaceuticals, Inc. | 1 | $23 |
| AbbVie | 1 | $19 |
| Maculogix, Inc. | 1 | $16 |
How this compares
$1,559 in reported general payments places this provider in the 70th percentile of 2,165 optometrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 21 | $958 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 45 | $832 |
| Latanoprost | 97 | $759 |
| Dorzolamide Hcl | 15 | $358 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 29 | $253 |
| Timolol Maleate | 23 | $196 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Altoona
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Leslie O DellNew Freedom$388K
- Kevin BistlinePlymouth Meeting$302K
- Thomas KislanStroudsburg$266K
- Erick HendersonPittsburgh$266K
- Ryan YealyLancaster$164K
- Joseph SmayNew Kensington$147K
- Julie McLaughlinAllentown$142K
- Robert RosenthalNewtown$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.